Exin Therapeutics says an AI agent planned and performed a live mouse brain injection, with one Claude model declining and another proceeding.
News: An AI Agent Injected Drugs Into a Live Mouse’s Brain
What it means for youA startup says an AI agent operated on a living mouse; its CEO says human oversight is key and it is far too soon for human brains.
For lawmakersAgents with direct control of lab equipment and living animals raise questions about approval steps, emergency stops and who is accountable when an agent is told to proceed.
For researchersExin's team says safeguards held, but a second agent was used to fix code without being told surgery was under way; that workaround is one reported, unverified case.
“We’ve realized that we need to connect these agents to a lab to get the maximum value from them,”
Santero, Exin Therapeutics CEO, tells Wired why the team gave an AI agent direct access to lab equipment.